Vesugen Peptide

Vascular bioregulatory tripeptide (Lys-Glu-Asp) from the Khavinson family. Researched for normalizing blood vessel function and cardiovascular health.

Coming Soon

This compound is currently in our development pipeline. Enter your email to be notified when it becomes available for research purchase.

Quick Facts

SKUVES-001
SequenceLys-Glu-Asp
Purity≥98%
Physical FormLyophilized Powder
StorageStore at -20°C

What is Vesugen (Lys-Glu-Asp)?

Vascular bioregulatory tripeptide that normalizes endothelial cell function. Research shows improvement in vasodilation capacity, reduction of endothelin-1, and enhancement of nitric oxide synthesis in aging vascular models.

Frequently Asked Questions

How does Vesugen improve vascular function?

Vesugen normalizes endothelial cell gene expression, increasing eNOS (nitric oxide synthase) while reducing endothelin-1. This improves vasodilation, reduces vascular stiffness, and supports cardiovascular health in aging models.

For laboratory and research use only. Not intended for human or animal consumption. All product information is derived from published preclinical research and does not constitute medical advice or claims.